Clinical Trial Detail

NCT ID NCT02579811
Title Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

clear cell renal cell carcinoma

Therapies

Axitinib

Age Groups: adult

No variant requirements are available.